Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-015981

Chief Operating Officer sold 465 shares at $2.61 ($1,214)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keuer Thomas A Chief Operating Officer 2017-02-28 Sale −465 $2.61 $1,214 14,435 D
Derivatives
Keuer Thomas A Chief Operating Officer 2017-02-27 Grant or award · Stock Option (right to buy) +23,800 23,800 D
Open-market sales · 465 sh · avg $2.61 · $1,214
Loading xslF345X03/doc4.xml…